Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
BIND Therapeutics
4210
BIND Therapeutics
Health Care
Technology
Biotechnology
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Suggest edits
Founded
2006
Raised
$37.9M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
NorthSea Therapeutics
Docturnal
OncoLens
Gracell Biotechnologies
Atelerix
Arctoris
InfoBionic
Immuneering Corp
Volastra Therapeutics
ReCode Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$25,500,000
Venture capital (Series D) - 2012
RUSNANO
$12,400,000
Venture capital (Series C) - 2010
Endeavour Vision
Flagship Ventures
Polaris Partners
+2
Team Size
50+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Xconomy
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M
Health
Legal
Xconomy
Bind Therapeutics Sheds Employees, Considers New Capital or Deals
Health
Funding
